Researchers are increasingly investigating retatrutide, a novel drug created by Eli Lilly, as a possible breakthrough in weight loss . Distinct from many previous approaches, retatrutide is a double -action agonist targeting simultaneously GLP-1 and GIP, substances that affect hunger and blood su